These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35281839)

  • 21. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.
    Jiang HZ; Yang B; Jiang YL; Liu X; Chen DL; Long FX; Yang Z; Tang DX
    Front Oncol; 2022; 12():1025397. PubMed ID: 36387195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell Senescence-Related Genes as Biomarkers for Prognosis and Immunotherapeutic Response in Colon Cancer.
    Haibo Z; Tianyun L; Xiaoman C; Xiaoyan H
    Biochem Genet; 2024 Feb; ():. PubMed ID: 38411939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
    Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
    Front Genet; 2021; 12():623424. PubMed ID: 33664769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
    Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
    Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer.
    Wang Z; Zhang Z; Zhang K; Zhou Q; Chen S; Zheng H; Wang G; Cai S; Wang F; Li S
    Front Oncol; 2022; 12():881953. PubMed ID: 35600382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 30. Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma.
    Zou Z; Chai Y; Li Q; Lin X; He Q; Xiong Q
    Front Oncol; 2022; 12():958221. PubMed ID: 36185199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations.
    Niu L; Liu L; Cai J
    Front Surg; 2023; 10():1079129. PubMed ID: 36843983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Hypoxia-Associated Gene Signature Depicts Tumor Immune Microenvironment and Predicts Prognosis of Colon Cancer Patients.
    Xu Y; Cao C; Zhu Z; Wang Y; Tan Y; Xu X
    Front Genet; 2022; 13():901734. PubMed ID: 35734431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer.
    Zhang X; Liang H; Tang Q; Chen H; Guo F
    Front Genet; 2022; 13():801665. PubMed ID: 35846123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer.
    Chen J; Apizi A; Wang L; Wu G; Zhu Z; Yao H; Chen G; Shi X; Shi B; Tai Q; Shen C; Zhou G; Wu L; He S
    J Gastrointest Oncol; 2021 Oct; 12(5):2244-2259. PubMed ID: 34790389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
    Jin Y; Deng J; Luo B; Zhong Y; Yu S
    Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
    Yin W; Jiang X; Tan J; Xin Z; Zhou Q; Zhan C; Fu X; Wu Z; Guo Y; Jiang Z; Ren C; Tang G
    Front Oncol; 2020; 10():1409. PubMed ID: 32974146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer.
    Guo T; Wang Z; Liu Y
    J Gastrointest Oncol; 2021 Oct; 12(5):2172-2191. PubMed ID: 34790383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.